Comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Endogenous Maternal Derived Androgen and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Genital appearance at birth | Atypical genital development may be present in an XX infant. | Genital findings are not the defining feature in available descriptions. | Moderate |
| Developmental delay | Not established as a core feature from the supplied description. | Developmental delay and intellectual disability are associated. | High |
| Congenital features | Primarily described as hormone-related atypical sex development. | Various congenital features may accompany the deletion. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 when
XX infant with atypical genitalia and suspected prenatal androgen exposure
The supplied mechanism is maternal-derived androgen crossing the placenta.
Moderate
Endocrine rather than chromosomal explanation is being considered
The listed category is endocrine and the body system is reproductive.
Moderate
Specialist assessment of sex development is needed
Management is described as involving pediatric specialists and possible hormone therapy.
Low
Choose 3q13 Microdeletion Syndrome C2931338 when
Child with developmental delay and congenital anomalies
These features are specifically associated with 3q13 microdeletion.
Moderate
A chromosomal cause is suspected
The condition is defined by missing material at chromosome 3q13.
High
Broader congenital syndrome evaluation is indicated
The listed category is genetic and the body system is congenital.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | 46,XX is part of the concept name. | Sex-chromosome result is not specified by the supplied data. | A karyotype alone does not establish either diagnosis. |
| Chromosomal microarray | No microdeletion is required by the supplied description. | May identify missing material involving 3q13. | Genetic confirmation should be interpreted by a genetics clinician. |
| Endocrine evaluation | May be relevant because maternal androgen exposure is proposed. | Not established as the primary diagnostic test. | Abnormal hormone results are findings, not a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- Outcome
- Long-term outcome is not established by the supplied data.
- Factors
- Reported severity is severe; course and response to specialist care may vary.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Outcome is variable and not quantified here.
- Factors
- Developmental disability and congenital features may influence function.
Time frame: Both are described as present from early life and chronic, with variable onset patterns.
Etiology, associated anomalies, developmental needs, and access to specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Psychosocial and identity concerns | May arise with atypical sex development; individual impact varies. May relate to disability and medical complexity rather than DSD specifically. Support needs should be individualized; no universal outcome is established. |
| Developmental impairment | Not established from the supplied source. Developmental delay and intellectual disability are associated. Severity and functional impact are variable and not quantified here. |
| Need for ongoing specialist care | Pediatric endocrine or DSD specialist involvement may be needed. Genetics, developmental, and congenital-care follow-up may be needed. Neither description establishes specific complication rates. |
Patient education highlights
- HighDistinct causes
One condition involves prenatal androgen effects in an XX fetus; the other involves missing chromosome 3q13 material.
- HighSpecialist confirmation
A test result or physical finding should be interpreted by qualified clinicians before a diagnosis is assigned.
- MediumVariable course
Both are described as chronic, but individual features, severity, and support needs can differ.